NCT02111850 2022-03-29T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 PositiveNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed21 enrolled 22 charts
NCT02153905 2019-06-17T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 PositiveNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated3 enrolled 14 charts
NCT00365287 2017-11-29Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerMasonic Cancer Center, University of MinnesotaPhase 1/2 Completed148 enrolled
NCT00048893 2012-04-13Vaccine and Chemotherapy for Previously Untreated Metastatic Breast CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated37 enrolled 9 charts